Search results
Janie Slaven: TONI SAYS: Why is Medicare Part D's IRMAA premium so high?
The Times-Tribune, Corbin, Ky. via Yahoo News· 11 hours agoApr. 19—Dear Toni: I am turning 65 in June, self-employed, and my income together with my wife's is over $300,000. Recently I received a letter from Social Security telling me that my monthly ...
Why doesn't Medicare cover drugs like Ozempic for weight loss? - Marketplace
Marketplace· 4 days agoMedicare Part D, which provides prescription drug coverage, will now cover the weight-loss...
How to save money at the pharmacy counter
Tribune via AOL· 5 days agoSteve Wexler has experienced the trouble of finding affordable prescription drugs in Minnesota. A few years ago, the 70-year-old Plymouth resident opted to cut short his & ...
Why are US pharmacy benefit managers under fire?
Reuters· 3 days agoMany lawmakers, drugmakers and government officials have pointed a finger at these industry middle men, suggesting they play a critical role in high ...
Biden law will cap Medicare drug cost including cancer drugs
Politifact· 1 day agoPart of President Joe Biden’s election year pitch to Latino voters includes a promise to lower...
Fact check: Biden is right about $35 insulin cap but exaggerates prior costs for Medicare enrollees
Medical Xpress· 4 days agoThe cost of insulin in the United States has risen considerably in recent years, with some estimates...
JD Supra: Déjà Vu: Biden’s 2025 Budget Nearly Identical on Health, Retirement
JD Supra· 1 day agoOn March 11, 2024, President Biden released his budget for Fiscal Year 2025. Although most of these proposals are unlikely to be considered or become law in this Congress with Republicans holding ...
CMS Issues CY2025 Medicare Advantage and Part D Final Rule
The National Law Review· 4 days agoAccording to CMS’ Fact Sheet, the Final Rule builds on existing Biden-Harris Administration policies...
Weight loss drugs may work for sleep apnea, Eli Lilly study finds
USA TODAY via Yahoo News· 3 days agoIt is the same medication as Mounjaro, which was approved by the FDA in May 2022 to treat type 2...
Promise of Eli Lilly's weight-loss drug for sleep apnea adds another reason to own the stock
CNBC· 2 days agoEli Lilly 's weight-loss drug Zepbound showed promise as a treatment for sleep apnea — giving...
